← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Colorado Research Partners, Llc
Centennial, CO
$7,552,009
Total funding
3
Grants
Funding over time
peak $1.5M · FY2015–23$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,552,009 · 3
By mechanism
U01$6,102,731 · 1
R42$1,265,585 · 1
R41$183,693 · 1
Investigators at Colorado Research Partners, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder$1,293,692
U01 · FY2019 · AA
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder$1,259,901
U01 · FY2020 · AA
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder$1,233,319
U01 · FY2021 · AA
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder$1,163,856
U01 · FY2022 · AA
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder$1,151,963
U01 · FY2023 · AA
Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity$769,627
R42 · FY2018 · DK
Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity$289,373
R42 · FY2017 · DK
Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity$206,585
R42 · FY2019 · DK
Scientific Merit and Feasibility of Fructokinase Inhibiton for Obesity$183,693
R41 · FY2015 · DK